Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and Neck
2012 ◽
Vol 82
(5)
◽
pp. 1845-1850
◽
Keyword(s):
Phase Ii
◽